<?xml version="1.0" encoding="UTF-8"?>
<p>Data from all children enrolled during the entire 7 years of IRIS were evaluated. Patients who received more than 1 NA inhibitor treatment or other antivirals were excluded. Children were stratified into age groups according to presumed immunity development [
 <xref rid="CIT0006" ref-type="bibr">6</xref>, 
 <xref rid="CIT0007" ref-type="bibr">7</xref>]: ≤6 months, 6 months−1 year, 1−3 years, 3−5 years, 5−10 years, and 10−13 years.
</p>
